Ukko
Biotechnology ResearchTel Aviv, Israel51-200 Employees
Ukko is a biotechnology company dedicated to designing safe immunotherapies to rapidly treat allergies and other immune-mediated conditions. Our proprietary technology platform has the potential to reduce or eliminate potentially dangerous allergic reactions, while inducing a protective immune response. By rethinking how to prevent allergic reactions at the molecular level, we aim to develop a safer, more precise alternative to traditional allergy desensitization methods, starting with individuals at risk for life-threatening allergic reactions to peanut.